Viewing Study NCT04308551


Ignite Creation Date: 2025-12-24 @ 11:56 PM
Ignite Modification Date: 2025-12-31 @ 3:48 AM
Study NCT ID: NCT04308551
Status: WITHDRAWN
Last Update Posted: 2024-11-20
First Post: 2020-03-06
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Effect of Indobufen and Aspirin on Platelet Aggregation and Long Term Prognosis in Patients With Coronary Heart Disease
Sponsor: Henan Institute of Cardiovascular Epidemiology
Organization:

Study Overview

Official Title: Effect of Indobufen and Aspirin on Platelet Aggregation and Long Term Prognosis in Patients With Stable Coronary Heart Disease. A Prospective, Randomized and Controlled,Single Blind, Single-center, Opening Study
Status: WITHDRAWN
Status Verified Date: 2024-11
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: shortage of funds
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: This study evaluates the effect of Indobufen and Aspirin on platelet aggregation and long term prognosis in patients with stable coronary heart disease.
Detailed Description: None

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: